PUMA BIOTECHNOLOGY INC (PBYI) is a publicly traded Healthcare sector company. As of May 21, 2026, PBYI trades at $7.00 with a market cap of $346.63M and a P/E ratio of 13.95. PBYI moved +2.50% today. Year to date, PBYI is +17.68%; over the trailing twelve months it is +92.56%. Its 52-week range spans $2.32 to $7.90. Analyst consensus is neutral with an average price target of $5.00. Rallies surfaces PBYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PBYI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PBYI recently traded at $7.00. Market cap is $346.63M. P/E ratio is 13.95. Revenue is $227.18M.
| Metric | Value |
|---|---|
| Price | $7.00 |
| Market Cap | $346.63M |
| P/E Ratio | 13.95 |
| EPS | $0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.90 |
| 52-Week Low | $2.32 |
| Volume | 33 |
| Avg Volume | 0 |
| Revenue (TTM) | $227.18M |
| Net Income | $24.38M |
| Gross Margin | 74.46% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $228.37M | $31.11M | $0.62 |
| 2023 | $235.64M | $21.59M | $0.46 |
| 2022 | $228.03M | $2.00K | $0.00 |
| 2021 | $253.16M | $-29.13M | $-29,126.00 |
1 analysts cover PBYI: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $5.00.